Lipid modification and coronary heart disease in type 2 diabetes: different from the general population?
Feher
M D
MD
Elkeles
R S
RS
D008076:Cholesterol, HDL / Q000378:metabolism; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000209:etiology* / Q000378:metabolism / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000188:drug therapy / Q000378:metabolism; D003925:Diabetic Angiopathies / Q000150:complications* / Q000188:drug therapy / Q000378:metabolism; D005260:Female; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008297:Male; D014280:Triglycerides / Q000378:metabolism
D008076:Cholesterol, HDL; D000960:Hypolipidemic Agents; D014280:Triglycerides